The Catheter Ablation Panel at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference was chaired by Robert C. Kowal, MD, PhD, FHRS, and included: Andrea Natale, MD, FHRS; Nassir Marrouche, MD, FHRS; and Sanjiv M. Narayan, MD, PhD. The video of the panel contains two hours of introductory and advanced …
Read More
The Managing AF Risk Factors Panel at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference included David J. Wilber, MD, FHRS speaking about the impact of Obesity, Diabetes, and Hypertension on Atrial Fibrillation; Susan Redline, MD, MPH speaking about Sleep Apnea as a Hidden Trigger for AF; and Mark S. …
Read More
A research study is currently enrolling paroxysmal afib patients (those with afib that comes and goes) to evaluate the effectiveness of an experimental drug. The study, being conducted in the US and Canada, will determine how well the study medication reduces the amount of time your heart is in afib. Learn more and see if …
Read More
In his talk about Avoiding Afib Strokes at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference, Dr. Mintu Turakhia of Stanford University discussed how our thinking about afib and stroke, and when to treat, has changed over the last couple of years. Access Dr. Turakhia’s talk at: Video: Avoiding Afib …
Read More
UPDATE 6-30-15: Thank you so much for your help. We've been asked to turn off this request as they have been swamped and have what they need. Have you, or a loved one, had a stroke or a stroke-like event (afib, chest pain, dizziness, palpitations, or fainting)? If so, you’re needed for some research. Find …
Read More
The VICTORY AF (Evaluation of Multielectrode Phased RF Technology in Persistent AF) Trial, sponsored by Medtronic, is studying patients undergoing a catheter ablation with Medtronic's Phased Radiofrequency (RF) system. To learn more, see: VICTORY AF Trial Studies Phased Radiofrequency (RF) System for Persistent and Longstanding Persistent Atrial Fibrillation
Read More
Here's more good news about the upcoming antidote for Eliquis - see: Positive Results for Factor Xa Inhibitor Antidote: ANNEXA-A
Read More
MedQuery Inc, a national medical market research company that collaborates with pharmaceutical and medical device companies, is looking for people who have been diagnosed with Atrial Fibrillation to participate in a face to face interview research study in NEW YORK on October 7th and 8th. This study is aimed at improving AF treatment and understanding …
Read More
Are you in the San Francisco area, or can you get there? Please join us for the Kickoff Conference of the Health eHeart Alliance Patient-Powered Research Network on November 6–7. We will identify research needs of the afib patient community and potential ways to address those needs. To learn more about the alliance and the …
Read More
Today, at the European Society of Cardiology Congress in Barcelona, it was reported that even though 80% of atrial fibrillation patients who should be on anticoagulants (according to their CHA2DS2-VASc score) are on anticoagulants, death rates at one year are still high. Most of those deaths are due to cardiovascular causes. The risk factors predicting …
Read More